BMO Capital initiated coverage of Alexandria Real Estate (ARE) with an Outperform rating and $100 price target The business has recently come under pressure due to “record-high” lab and office new supply and demand headwinds, the analyst tells investors in a research note. The firm cites positive trends in the biopharma industry and the stock’s discounted valuation for the Outperform rating.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARE:
- Alexandria Real Estate: A Strategic Buy Amidst Temporary Challenges and Long-term Opportunities
- Alexandria Real Estate upgraded to Outperform from In Line at Evercore ISI
- Alexandria Real Estate price target lowered to $98 from $100 at RBC Capital
- Alexandria Real Estate Equities’ Positive Earnings Call Highlights
- Alexandria Real Estate price target raised to $91 from $89 at Evercore ISI